Hara Y - Search Results

1

[Effect of arotinolol on the incomplete tetanic contractions of the cat soleus muscle--relation to its anti-tremorgenic action].

Hara Y, Sugimoto S, Ono H. Hara Y, et al. Nihon Yakurigaku Zasshi. 1993 Aug;102(2):141-51. doi: 10.1254/fpj.102.141. Nihon Yakurigaku Zasshi. 1993. PMID: 7690340 Japanese.

2

Preparation of specific antisera to 15alpha-hydroxyestrogens.

Suzuki E, Nakagomi M, Hashimoto M, Agui M, Iida S, Konno K, Hara Y, Kurihara H, Matsuki Y, Imai K, Ono H. Suzuki E, et al. Among authors: hara y. Steroids. 1999 Aug;64(8):551-7. doi: 10.1016/s0039-128x(99)00031-8. Steroids. 1999. PMID: 10493601

3

[Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].

Hara Y, Nakahara H, Miyagishi A, Nakatani H. Hara Y, et al. Nihon Yakurigaku Zasshi. 1983 Aug;82(2):103-16. Nihon Yakurigaku Zasshi. 1983. PMID: 6198264 Japanese.

4

Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.

Miyagishi A, Maniwa T, Noguchi T, Hara Y. Miyagishi A, et al. Among authors: hara y. Clin Exp Hypertens A. 1991;13(5):1077-89. doi: 10.3109/10641969109042114. Clin Exp Hypertens A. 1991. PMID: 1723031

5

[Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].

Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H. Hara Y, et al. Nihon Yakurigaku Zasshi. 1979 Oct;75(7):707-20. Nihon Yakurigaku Zasshi. 1979. PMID: 94296 Japanese.

6

Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.

Miyagishi A, Nakahara H, Hara Y. Miyagishi A, et al. Among authors: hara y. Arch Int Pharmacodyn Ther. 1984 Oct;271(2):249-62. Arch Int Pharmacodyn Ther. 1984. PMID: 6210068

7

Effects of the new beta-adrenoceptor blocking agent, S-596 on the peripheral autonomic nervous system and smooth muscles.

Miyagishi A, Nakahara H, Hara Y, Nakatani H. Miyagishi A, et al. Among authors: hara y. Arch Int Pharmacodyn Ther. 1983 Feb;261(2):222-37. Arch Int Pharmacodyn Ther. 1983. PMID: 6188420

8

Synthesis and beta-adrenergic blocking action of a new thiazolylthiopropanolamine derivative.

Hara Y, Sato E, Miyagishi A, Aisaka A, Hibino T. Hara Y, et al. J Pharm Sci. 1978 Sep;67(9):1334-5. doi: 10.1002/jps.2600670944. J Pharm Sci. 1978. PMID: 29117

9

Mesoscale heterogeneity is a critical determinant for spiral pattern formation in developing social amoeba.

Kakizuka T, Nakaoka H, Hara Y, Ichiraku A, Arai Y, Itoga H, Onami S, Ichimura T, Nagai T, Horikawa K. Kakizuka T, et al. Among authors: hara y. Sci Rep. 2025 Jan 9;15(1):1422. doi: 10.1038/s41598-025-85759-9. Sci Rep. 2025. PMID: 39789232 Free PMC article.

10

Study on the relationship between microbial composition within obstructive biliary stents and the severity of obstruction and duration of stent placement.

Sugawara I, Kawahara Y, Takayasu L, Isshi K, Kato M, Ono S, Hara Y, Futakuchi T, Furuhashi H, Kurokawa R, Sumiyama K, Suda W. Sugawara I, et al. Among authors: hara y. PLoS One. 2025 Jan 9;20(1):e0317230. doi: 10.1371/journal.pone.0317230. eCollection 2025. PLoS One. 2025. PMID: 39787171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,869 results

Search Page

Filters